PLASMENYLETHANOLAMINE FACILITATES RAPID MEMBRANE-FUSION - A STOPPED-FLOW KINETIC INVESTIGATION CORRELATING THE PROPENSITY OF A MAJOR PLASMA-MEMBRANE CONSTITUENT TO ADOPT AN H-II PHASE WITH ITS ABILITY TO PROMOTE MEMBRANE-FUSION

被引:188
作者
GLASER, PE [1 ]
GROSS, RW [1 ]
机构
[1] WASHINGTON UNIV, SCH MED, DIV BIOORGAN CHEM & MOLEC PHARMACOL, ST LOUIS, MO 63110 USA
关键词
D O I
10.1021/bi00185a019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A critical step in membrane fusion involves the formation of a lipid intermediate which shares a conformational similarity with an inverted hexagonal phase (H-II). Since plasmenylethanolamines possess a marked propensity for hexagonal phase formation and represent a major lipid constituent of several membrane systems which undergo rapid membrane fusion (e.g., plasma membranes and synaptic vesicle membranes), we compared the relative fusogenicity of lipid vesicles containing plasmenylethanolamine to that of vesicles containing their diacyl phospholipid counterpart (i.e., phosphatidylethanolamine). Vesicles comprised of equimolar mixtures of phosphatidylcholine and phosphatidylethanolamine fused slowly with phosphatidylserine vesicles in the presence of 10 mM CaCl2, as assessed either by lipid mixing (dequenching of octadecyl rhodamine fluorescence, 7.4F(max%)s(-1)) or internal contents mixing (fluorescence enhancement from the resultant Tb/dipicolinic acid charge transfer complex, 8.7F(max%)s(-1)). In stark contrast, vesicles comprised of equimolar mixtures of phosphatidylcholine and plasmenylethanolamine fused three times more rapidly, as assessed by both lipid mixing (22.1F(max%)s(-1)) and internal contents mixing (21.4F(max%)s(-1)) assays. The importance of an H-II-like intermediate in membrane fusion was further substantiated by demonstration that plasmenylethanolamines containing arachidonic acid at the sn-2 position (which demonstrate a greater propensity for H-II phase formation) exhibited the most rapid rate of membrane fusion (five times greater than phosphatidylethanolamine containing oleic acid at the sn-2 position). Furthermore, vesicles containing plasmenylethanolamines in physiologic ratios with other phospholipids (i.e., PC/PE/PS, 45:45:10, mol/mol) underwent fusion six times more rapidly (4.4F(max%)min(-1)) than corresponding vesicles in which plasmenylethanolamine was replaced with phosphatidylethanolamine (0.7F(max%)min(-1)). Collectively, these studies demonstrate the importance of plasmalogens containing arachidonic acid in facilitating membrane fusion and further substantiate the importance of an H-II-like intermediate in membrane fusion events.
引用
收藏
页码:5805 / 5812
页数:8
相关论文
共 48 条
[1]   MEMBRANE CONTACT, FUSION, AND HEXAGONAL (HII) TRANSITIONS IN PHOSPHATIDYLETHANOLAMINE LIPOSOMES [J].
ALLEN, TM ;
HONG, K ;
PAPAHADJOPOULOS, D .
BIOCHEMISTRY, 1990, 29 (12) :2976-2985
[2]   TRANSMITTER RELEASE FROM SYNAPSES - DOES A PREASSEMBLED FUSION PORE INITIATE EXOCYTOSIS [J].
ALMERS, W ;
TSE, FW .
NEURON, 1990, 4 (06) :813-818
[3]  
BENTZ J, 1988, COLLOID SURFACE, V30, P65
[4]   DESTABILIZATION OF PHOSPHATIDYLETHANOLAMINE-CONTAINING LIPOSOMES - HEXAGONAL PHASE AND ASYMMETRIC MEMBRANES [J].
BENTZ, J ;
ELLENS, H ;
SZOKA, FC .
BIOCHEMISTRY, 1987, 26 (08) :2105-2116
[5]   IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR ISOLATION OF PLATELET-ACTIVATING FACTOR FROM OTHER PHOSPHOLIPIDS [J].
BLANK, ML ;
SNYDER, F .
JOURNAL OF CHROMATOGRAPHY, 1983, 273 (02) :415-420
[6]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[7]   ADULT RAT-BRAIN SYNAPTIC VESICLES .2. LIPID COMPOSITION [J].
BRECKENRIDGE, WC ;
MORGAN, IG ;
ZANETTA, JP ;
VINCENDON, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 320 (03) :681-686
[8]   LYSOLIPIDS REVERSIBLY INHIBIT CA-2+-DEPENDENT, GTP-DEPENDENT AND PH-DEPENDENT FUSION OF BIOLOGICAL-MEMBRANES [J].
CHERNOMORDIK, LV ;
VOGEL, SS ;
SOKOLOFF, A ;
ONARAN, HO ;
LEIKINA, EA ;
ZIMMERBERG, J .
FEBS LETTERS, 1993, 318 (01) :71-76
[9]   LIPID POLYMORPHISM AND THE FUNCTIONAL ROLES OF LIPIDS IN BIOLOGICAL-MEMBRANES [J].
CULLIS, PR ;
DEKRUIJFF, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 559 (04) :399-420
[10]  
CULLIS PR, 1991, BIOCH LIPIDS LIPOPRO